It is possible that other vascular risk factors and vascular risk measured at mid-life (prior to the accumulation of tau) provides a better relationship with AD pathology at older age, as has also been suggested by previous studies,57 which would be of interest for a future study. The gene discussed is MAPT; the disease is Alzheimer disease.